Modalis Therapeutics Corp (4883)

Currency in JPY
31.0
+1.0(+3.33%)
Delayed Data·
Earnings results expected in 6 days
4883 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
30.033.0
52 wk Range
29.097.0
Key Statistics
Bid/Ask
31.00 / 32.00
Prev. Close
30
Open
31
Day's Range
30-33
52 wk Range
29-97
Volume
1.92M
Average Volume (3m)
1.82M
1-Year Change
-65.2174%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4883 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Modalis Therapeutics Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
ICICI Securities
Buy385.00+1,141.94%400.00MaintainMay 13, 2026
Jefferies
Buy410.00+1,222.58%425.00MaintainApr 09, 2026
Jefferies
Buy430.00+1,287.10%455.00MaintainJan 06, 2026
Axis Capital Limited
Buy459.00+1,380.65%463.00MaintainOct 30, 2025

Earnings

Latest Release
May 13, 2026
EPS / Forecast
-3.64 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

4883 Income Statement

Compare 4883 to Peers and Sector

Metrics to compare
4883
Peers
Sector
Relationship
P/E Ratio
−1.6x−8.5x−0.4x
PEG Ratio
−0.09−0.150.00
Price/Book
1.0x3.6x2.6x
Price / LTM Sales
-20.6x3.0x
Upside (Analyst Target)
-149.9%54.3%
Fair Value Upside
Unlock9.2%8.4%Unlock

Modalis Therapeutics Corporation engages in the research and development of therapeutics to treat patients with serious genetic disorders. The company is developing therapies for genetic diseases using its proprietary CRISPR-GNDM an epigenome editing technology that combines dCas9. It also develops various therapeutics for muscle disorders, cardiomyopathy, and CNS disorders. The company was formerly known as EdiGENE Corporation and changed its name to Modalis Therapeutics Corporation in August 2019. Modalis Therapeutics Corporation was incorporated in 2016 and is headquartered in Chuo, Japan.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.70K0.00%51.00K
Other Institutional Investors
15.73M16.16%471.87M
Public Companies & Retail Investors
81.60M83.84%2.45B
Total
97.33M100.00%2.92B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Evo Fund3.05%2,970,00089,100
Evolution Capital Management LLC3.05%2,970,00089,100

People Also Watch

10,060.0
6269
+0.25%
14,640.0
4004
+4.13%
4,002.00
5016
+4.11%

FAQ

What Is the Modalis (4883) Stock Price Today?

The Modalis stock price today is 31.0 JPY.

What Stock Exchange Does Modalis Trade On?

Modalis is listed and trades on the Tokyo Stock Exchange.

What Is the Stock Symbol for Modalis?

The stock symbol for Modalis is "4883."

What Is the Modalis Market Cap?

As of today, Modalis market cap is 2.92B JPY.

What Is Modalis's Earnings Per Share (TTM)?

The Modalis EPS (TTM) is -22.4.

When Is the Next Modalis Earnings Date?

Modalis will release its next earnings report on Aug 10, 2026.

From a Technical Analysis Perspective, Is 4883 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Modalis Stock Split?

Modalis has split 0 times.

How Many Employees Does Modalis Have?

Modalis has 17 employees.

What is the current trading status of Modalis (4883)?

As of Aug 04, 2026, Modalis (4883) is trading at a price of 31.0 JPY, with a previous close of 30.0 JPY. The stock has fluctuated within a day range of 30.0 JPY to 33.0 JPY, while its 52-week range spans from 29.0 JPY to 97.0 JPY.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.